ClinicalTrials.gg
RecruitingNCT06761170Cryo-BASUpdated Nov 10, 2026

Spray Cryotherapy for the Management of Benign Central Airway Stenosis (Cryo-BAS)

A Phase 2 interventional study of Spray cryo therapy and Standard of Care (SOC) in Stenosis of Trachea, sponsored by Beth Israel Deaconess Medical Center. Recruiting at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Beth Israel Deaconess Medical Center · Phase 2, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jun 2025; still recruiting 1 year 5 months later.
Updated Nov 10, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2
Study type
Interventional
Enrollment
50
Allocation
Randomized
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 11 studies in Tracheal Stenosis with a site in United States — 7 open to participants now, 7 under way, none of them phase 3. Tracheal Stenosis · United States.

Started
2025
with 1 other
Phase 2
Only one
of the 11
Registered
8th of 11
by date
Lead sponsor
2 of 11
Beth Israel Deaconess Medical Center

Among the 11 studies in Tracheal Stenosis with a site in United States, this one is one of 2 that started in 2025, is the only one in phase 2, and was the 8th registered.

Tracheal Stenosis

42 studies on the registry are indexed under Tracheal Stenosis; 11 are open to participants now.

Browse Tracheal Stenosis studies →

Open to participants now

7 of the 11 studies in Tracheal Stenosis with a site in United States are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 8 Tracheal Stenosis studies recruiting now, 6 set no upper age limit and none stop at 75 or younger; 3 take children under 18; none take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Tracheal Stenosis with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is to compare spray cryotherapy plus balloon dilatation versus current standard of Care (SoC - steroid injection, radial cuts and balloon dilatation) in patients with benign airway stenosis with simple stenosis. The main question[s] investigators aim to answer are:

  1. What is the need for reintervention and time to reintervention in participants with benign airway stenosis with simple stenosis who receive spray cryotherapy plus balloon dilatation versus standard of care alone?
  2. To evaluate patient experience, physiological, anatomical changes, health care utilization and safety of the SCT plus balloon dilatation versus standard of care alone.

Researchers will compare spray cryotherapy plus balloon dilatation versus current standard of Care (SoC - steroid injection, radial cuts and balloon dilatation) in patients with benign airway stenosis with simple stenosis to see if it reduces the need of re intervention.

Participants will surgery and receive one of the two interventions.

Read the detailed description

Investigators propose a single center, single-blinded (patient), randomized 1:1 trial comparing SCT plus Balloon dilatation (experimental group) vs SoC alone (control group). Investigators aim to recruit 50 patients.

Study will span 2-year duration with 1 year recruitment. Follow up at 6 weeks, 3 months, 6 months, 12 months. The patient's airway will be either a laryngeal mask airway or a rigid bronchoscopy for passive venting and gas egress.

03

Conditions studied

  • Stenosis of Trachea

Browse trials for

Keywords

  • Stenosis of trachea
  • benign
  • spray cryotherapy
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 1. Patients with symptomatic, benign, simple stenosis of the trachea and/or subglottic space.
  • 2. Stenotic airway of diameter \< 1cm.

Exclusion criteria

Exclusion Criteria:

  1. Complex stenosis, cartilage involvement (malacia or fracture).
  2. Patients with giant bullae (> a third of hemithorax) or bullae >3cm.
  3. Concurrent tracheoesophageal fistula, active tracheal .
  4. Presence of concomitant upper airway obstruction.
  5. Pregnancy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Interventional

    1. Stenotic lumen diameter \> 8mm: 1. Spray Cryo Therapy for 5s, repeated 3-5 cycles 2. Balloon dilation (to normal airway diameter) 2. Stenotic lumen diameter \< 8mm 1. Balloon dilation (up to 8mm diameter) 2. Spray Cryo Therapy for 5s, repeated 3-5 cycles 3) Balloon dilation (to normal airway diameter)

    Procedure: Spray cryo therapy

  • Active comparator
    Control

    1. Steroid injection 2. Radial mucosal incision 3. Balloon dilation (to normal airway diameter)

    Procedure: Standard of Care (SOC)

Interventions

  • ProcedureSpray cryo therapy

    normal flow, 5 seconds repeated for 3-5 cycles

  • ProcedureStandard of Care (SOC)

    1. Steroid injection 2. Radial mucosal incision 3. Balloon dilation (to normal airway diameter)

06

What researchers measure

Primary outcomes

  1. Need of re intervention

    Number of patients that require new intervention for the benign airway stenosis.

    Time frame: Need of re intervention in two years

Secondary outcomes

  1. Time to re intervention

    Time it takes in days for a patient to need a re intervention for the benign airway stenosis after treatment.

    Time frame: Two years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Leong P, Bardin PG, Lau KK. What's in a name? Expiratory tracheal narrowing in adults explained. Clin Radiol. 2013 Dec;68(12):1268-75. doi: 10.1016/j.crad.2013.06.017. Epub 2013 Aug 13. PubMed 23953005 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Jun 2025 (actual). Primary completion is estimated for Jan 2028, 31 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 10, 2026: primary completion Jan 2027 → Jan 2028 and completion Jan 2027 → Jan 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 23, 2024
First posted
Jan 7, 2025
StartActual
Jun 2, 2025
Primary completionEst.
Jan 15, 2028was Jan 2027
CompletionEst.
Jan 15, 2028was Jan 2027
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jan 15, 2027→Jan 15, 2028
Nov 10, 2026
Study completion
Jan 15, 2027→Jan 15, 2028
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    Primary completion Jan 15, 2027→Jan 15, 2028
    Study completion Jan 15, 2027→Jan 15, 2028
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06761170
Collaborators
American Association of Broncology and Interventional Pulmonology
Responsible party
Adnan Majid, MD (Chief, Section of Interventional Pulmonology, Division of Thoracic Surgery and Interventional Pulmonology, Beth Israel Deaconess Medical Center, Professor of Medicine, Harvard Medical School,, Beth Israel Deaconess Medical Center) — Principal investigator
First posted
Jan 7, 2025
Start date
Jun 2, 2025
Primary completion
Jan 15, 2028 (estimated)
Completion
Jan 15, 2028 (estimated)
Last update
Nov 10, 2026

Study contacts

Christine Conley
Contact
Cconley@bidmc.harvard.edu
617-632-8386

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion